Search Results for “”

Showing 1-10 of 31

April 29, 2019

FDA: Jurox voluntarily recalls two lots of Alfaxan after reports of adverse side effects, including one death

After receiving adverse reports involving five animals, Australia-based Jurox Animal Health voluntarily recalled two lots of the widely used intravenous injectable anesthetic Alfaxan unpreserved last week, according to the US Food and Drug Administration (FDA). The reason for the recall: The presence of aluminum phosphate precipitate, which, when injected, presents a possible risk of blood vessel inflammation and formation of potentially life-threatening blood clots.

January 24, 2019

AVMA Council on Education seeking volunteers

You could have a say on the future of veterinary education. The American Veterinary Medical Association (AVMA) Council on Education (COE) Selection Committee is seeking interested and qualified veterinarians to serve on the council. Per the AVMA, “This is one of the most important volunteer roles that AVMA members can fill.”

August 29, 2018

AAHA joins other veterinary leaders in call for strong licensure requirements

When it’s all about quality of care, everyone’s on board. The American Veterinary Medical Association (AVMA), American Association of Veterinary State Boards (AAVSB), Association of American Veterinary Medical Colleges (AAVMC) and National Association of Veterinary Technicians in America (NAVTA) on Thursday released a joint statement of support for

December 14, 2017

FDA says shortage of pain relief drugs due to manufacturing issue

The U.S. Food and Drug Administration (FDA) is reporting a shortage of three pain relief drugs: fentanyl, morphine and hydromorphone. The shortage is due to upgrades being made at a pharmaceutical manufacturing plant in Kansas, and is unrelated to any federal policies on opioids or manufacturing quotas, according to FDA officials.

October 12, 2015

Protect ketamine use in the United States

The World Health Organization (WHO) may be considering another proposed change to the international scheduling of ketamine, and the AVMA is seeking the profession’s help in asking the US Food and Drug Administration (FDA) to protect veterinarians’ access to this critical drug. The AVMA is drafting a letter to the FDA that will outline how critical ketamine use is in veterinary medicine and how important it is that it remain available to U.S. veterinarians, and is requesting your help during this urgent time to reinforce the message.

December 09, 2014

Tax Planning for 2014 – Finally Some Answers

It appears that Congress will pass an eleventh-hour Tax Extenders Bill, a package of 55 tax breaks for businesses and individuals that will cost approximately $45 billion.

August 01, 2018

FDA approves cannabis for treating pets (sort of)

The US Food and Drug Administration (FDA) gave veterinarians the green light to use cannabis in the treatment of pets—in a manner of speaking. Put it this way: It didn’t say they couldn’t. Here’s what happened.

May 04, 2017

Weekly News Roundup 4/27 – 5/4

Catch up on the latest pet and veterinary news from the last week. In this update: a New York bill proposes banning declawing, the FDA sends warning letters about unproven cancer treatment claims, the University of Arizona faces new hurdle in creating veterinary school, and the world welcomes a litter of endangered red wolf pups.

December 10, 2018

FDA approves drug for dogs with noise aversion (but not in time for New Year’s Eve)

The US Food and Drug Administration’s (FDA) Center for Veterinary Medicine recently approved Pexion (imepitoin tablets) to treat noise aversion in dogs. It’s a common condition—one study found that 40% of dogs may suffer from some degree of noise aversion—and one with possibly serious health implications, indicates a study that shows that noise aversion in dogs could be a sign of serous pain.

Refine Results


NEWStat

keyboard_arrow_down keyboard_arrow_up